VISIONEERING TECHNOLOGIES INC (VTI)
Share Price Analysis and Chart
Enter the company code or Name for stock analysis:
VTI - VISIONEERING TECHNOLOGIES INC
FNArena Sector : Medical Equipment & Devices
Year End: December
GICS Industry Group : Health Care Equipment & Services
Debt/EBITDA: -0.48
Index:
Visioneering Technologies is headquartered in Alpharetta, Georgia, USA and specialises in design, sale and distribution of NaturalVue contact lenses.
| LAST PRICE | CHANGE +/- | CHANGE % | VOLUME |
|---|---|---|---|
|
$0.23
26 May |
OPEN $0.23 |
HIGH $0.29 |
30,647 LOW $0.23 |
0.010| OTHER COMPANIES IN THE SAME SECTOR | |||
| 4DX . AHZ . AT1 . BRN . CAT . CBL . CGS . CMP . COH . CSX . CU6 . CYC . EBR . ELX . EMV . EYE . FPH . HLA . IDX . IME . IMR . IPD . LDX . LHC . MEB . MX1 . NAN . ONE . OVN . PCK . PEB . PGC . PME . RAP . RMD . RVA . SOM . TRJ . UBI . VHT . | |||
FNARENA'S MARKET CONSENSUS FORECASTS
- No Record -
HISTORICAL DATA ARE ALL IN AUD
Copyright © 2023 FactSet UK Limited. All rights reserved
| Title | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 |
|---|---|---|---|---|---|---|
| EPS Basic | xxx | xxx | xxx | xxx | xxx | -33.2 |
| DPS All | xxx | xxx | xxx | xxx | xxx | 0.0 |
| Sales/Revenue | xxx | xxx | xxx | xxx | xxx | 10.5 M |
| Book Value Per Share | xxx | xxx | xxx | xxx | xxx | 29.6 |
| Net Operating Cash Flow | xxx | xxx | xxx | xxx | xxx | -8.6 M |
| Net Profit Margin | xxx | xxx | xxx | xxx | xxx | -80.36 % |
EPS Basic
DPS All
Sales/Revenue
Book Value Per Share
Net Operating Cash Flow
Net Profit Margin
| Title | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 |
|---|---|---|---|---|---|---|
| Return on Capital Employed | xxx | xxx | xxx | xxx | xxx | -73.12 % |
| Return on Invested Capital | xxx | xxx | xxx | xxx | xxx | -58.29 % |
| Return on Assets | xxx | xxx | xxx | xxx | xxx | -49.76 % |
| Return on Equity | xxx | xxx | xxx | xxx | xxx | -73.12 % |
| Return on Total Capital | xxx | xxx | xxx | xxx | xxx | -56.82 % |
| Free Cash Flow ex dividends | xxx | xxx | xxx | xxx | xxx | - |
Return on Capital Employed
Return on Invested Capital
Return on Assets
Return on Equity
Return on Total Capital
Free Cash Flow ex dividends
| Title | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 |
|---|---|---|---|---|---|---|
| Short-Term Debt | xxx | xxx | xxx | xxx | xxx | 0 M |
| Long Term Debt | xxx | xxx | xxx | xxx | xxx | 2 M |
| Total Debt | xxx | xxx | xxx | xxx | xxx | 2 M |
| Goodwill - Gross | xxx | xxx | xxx | xxx | xxx | - |
| Cash & Equivalents - Generic | xxx | xxx | xxx | xxx | xxx | 7 M |
| Price To Book Value | xxx | xxx | xxx | xxx | xxx | 1.35 |
Short-Term Debt
Long Term Debt
Total Debt
Goodwill - Gross
Cash & Equivalents - Generic
Price To Book Value
| Title | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 |
|---|---|---|---|---|---|---|
| Capex | xxx | xxx | xxx | xxx | xxx | 0.0 M |
| Capex % of Sales | xxx | xxx | xxx | xxx | xxx | 0.05 % |
| Cost of Goods Sold | xxx | xxx | xxx | xxx | xxx | 6 M |
| Selling, General & Admin. Exp & Other | xxx | xxx | xxx | xxx | xxx | 13 M |
| Research & Development | xxx | xxx | xxx | xxx | xxx | 4 M |
| Investments - Total | xxx | xxx | xxx | xxx | xxx | - |
Capex
Capex % of Sales
Cost of Goods Sold
Selling, General & Admin. Exp & Other
Research & Development
Investments - Total
EXPERT VIEWS
Display All Commentary
Sentiment Indicator
No. Of Recommendations
VTI STOCK CHART
FNArena News on VTI
| 1 |
Australian Broker Call *Extra* Edition – Oct 11, 2021Oct 11 2021 - Daily Market Reports |
| 2 |
Australian Broker Call *Extra* Edition – Sep 17, 2021Sep 17 2021 - Daily Market Reports |
| 3 |
Australian Broker Call *Extra* Edition – Oct 28, 2020Oct 28 2020 - Daily Market Reports |
| 4 |
The Wrap: Regional Banks & Financial AdviceMay 26 2017 - Weekly Reports |
Latest Medical Equipment & Devices News
| 1 |
Dr Boreham’s Crucible: ImpedimedMay 08 2023 - Small Caps |
| 2 |
Treasure Chest: ResMed’s Benevolent MonopolyMay 01 2023 - Treasure Chest |
| 3 |
Dr Boreham’s Crucible: Volpara Health TechnologiesApr 26 2023 - Small Caps |
| 4 |
Dr Boreham’s Crucible: SDIMar 16 2023 - Small Caps |
| 5 |
Dr Boreham’s Crucible: CochlearMar 03 2023 - Australia |
| 6 |
Dr Boreham’s Crucible: Imagion BiosystemsFeb 13 2023 - Small Caps |
| 7 |
ResMed: Philips Remains The Big UnknownJan 31 2023 - Australia |
| 8 |
Nanosonics Outlook Remains CloudedJan 24 2023 - Small Caps |
| 9 |
Nanosonics Recovers On Less Negative SentimentNov 29 2022 - Small Caps |
| 10 |
Treasure Chest: Fisher & Paykel HealthcareNov 16 2022 - Treasure Chest |
